RUNX2 and Miyoshi myopathy: Overexpression of miR-342 and miR-363 in CAG MM cells, individually or in combination, suppressed Runx2 protein levels, with concomitant inhibition of Akt/β-catenin/survivin, known targets of Runx2, leading to a strong reduction of MM cell proliferation.